Published in J Hepatol on November 01, 1996
Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol (2006) 2.77
Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol (2006) 2.68
Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis (2010) 1.06
Binding of liver derived, low density hepatitis C virus to human hepatoma cells. J Med Virol (2008) 0.83
Hepatitis C virus heterogeneity: lipoprotein and immunoglobulin binding and clinical status. J Clin Exp Hepatol (2013) 0.75
An unusually large multifunctional polypeptide in the erythromycin-producing polyketide synthase of Saccharopolyspora erythraea. Nature (1990) 3.81
Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies. Immunol Rev (1983) 3.70
Natural history of early primary biliary cirrhosis. Lancet (1996) 3.24
MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen. J Exp Med (1983) 2.72
Comparative virulence of respiratory syncytial virus subgroups A and B. Lancet (1989) 2.03
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol (2000) 2.01
Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology (1997) 1.94
Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet (1988) 1.90
Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology (1998) 1.84
Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet (1983) 1.78
Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut (2000) 1.68
Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci U S A (1988) 1.62
Nucleoside analogue therapy in fibrosing cholestatic hepatitis--a case report in an HBsAg positive renal transplant recipient. Liver (1998) 1.45
The relation of pyrexia and nasal inflammatory response to virus levels in nasal washings of ferrets infected with influenza viruses of differing virulence. Br J Exp Pathol (1977) 1.43
Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection. J Gen Virol (1990) 1.43
Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: a UK multicentre study. J Hepatol (2001) 1.42
Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology (1981) 1.38
Breast-feeding and respiratory syncytial virus infection. Br Med J (1980) 1.36
Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol (1999) 1.36
Risk factors and medical follow-up of drug users tested for hepatitis C--can the risk of transmission be reduced? Drug Alcohol Rev (1997) 1.35
Hepatitis C virus antibody. Lancet (1989) 1.33
Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology (1987) 1.32
Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody. J Med Virol (2002) 1.32
Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens. Clin Exp Immunol (1989) 1.32
The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man. Br J Exp Pathol (1976) 1.27
Strain variation of respiratory syncytial virus. J Gen Virol (1987) 1.26
Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient. Br J Clin Pharmacol (1987) 1.26
Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol (1992) 1.26
The development of monoclonal antibodies to respiratory syncytial virus and their use in diagnosis by indirect immunofluorescence. J Med Virol (1985) 1.22
CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol (2000) 1.21
Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. J Hepatol (1999) 1.20
Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut (1994) 1.18
Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology (1992) 1.18
Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut (1996) 1.17
Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci U S A (1990) 1.17
Heterogeneity of the respiratory syncytial virus 22K protein revealed by Western blotting with monoclonal antibodies. J Gen Virol (1987) 1.16
HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine. Br Med J (1978) 1.15
Hypogammaglobulinaemia with absent B lymphocytes and agranulocytosis after carbamazepine treatment. J Neurol Neurosurg Psychiatry (1996) 1.13
The localization of influenza virus: minimal infectious dose determinations and single cycle kinetic studies on organ cultures of respiratory and other ferret tissues. Br J Exp Pathol (1974) 1.13
Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut (2005) 1.11
The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice. J Gen Virol (1988) 1.11
Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis (1997) 1.11
Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology (1990) 1.10
Identification of DEBS 1, DEBS 2 and DEBS 3, the multienzyme polypeptides of the erythromycin-producing polyketide synthase from Saccharopolyspora erythraea. FEBS Lett (1992) 1.10
Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology (1991) 1.09
Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas. J Hepatol (1992) 1.06
Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED. Clin Exp Immunol (2008) 1.06
Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. Br Med J (Clin Res Ed) (1983) 1.05
Best practice in primary care pathology: review 2. J Clin Pathol (2006) 1.05
Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analysed by single platform flow cytometry. Clin Exp Immunol (2005) 1.03
A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol (1992) 1.03
Primary liver cell cancer in Britain--a viral aetiology? Br Med J (1979) 1.02
An enzyme-linked immunosorbent assay (ELISA) for IgG and IgA antibodies to respiratory syncytial virus in low dilutions of secretions of human serum and secretions. J Med Virol (1984) 1.02
Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology (1997) 1.01
The E1 alpha and beta subunits of the pyruvate dehydrogenase complex are M2'd' and M2'e' autoantigens in primary biliary cirrhosis. Clin Sci (Lond) (1989) 1.01
Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age. Age Ageing (1994) 1.00
Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells. Hepatology (1996) 1.00
Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol (2007) 1.00
The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics (1998) 1.00
Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency. Clin Exp Immunol (1991) 0.99
Managing chronic hepatitis C acquired through intravenous drug use. QJM (2001) 0.99
T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology (1995) 0.99
Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO. Arch Dis Child (2003) 0.96
Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology (1989) 0.96
Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies. J Clin Pathol (1999) 0.96
Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: lack of a polymorphism in CYP1A2 in Caucasians. Pharmacogenetics (1999) 0.96
Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev (1999) 0.94
A monoclonal antibody pool for routine immunohistochemical detection of human respiratory syncytial virus antigens in formalin-fixed, paraffin-embedded tissue. J Pathol (1997) 0.94
Immunoglobulin concentrations in nasopharyngeal secretions. Arch Dis Child (1984) 0.94
Characterisation of the reactivity of autoantibodies in primary biliary cirrhosis. FEBS Lett (1989) 0.94
Secretion of respiratory syncytial virus inhibitors and antibody in human milk throughout lactation. J Med Virol (1980) 0.94
Best practice in primary care pathology: review 6. J Clin Pathol (2006) 0.93
New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry. J Pathol (1997) 0.93
A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein. J Gen Virol (1986) 0.93
Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-gamma) production. Clin Exp Immunol (1996) 0.93
Mammary immunity in mothers of infants with respiratory syncytial virus infection. J Med Virol (1987) 0.92
Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis. Hepatology (1999) 0.92
Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. A phase II study. J Hepatol (1987) 0.92
A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut (1997) 0.92
HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut (1985) 0.92
How to test for antineutrophil cytoplasmic antibodies--evidence based immunology? J Clin Pathol (1999) 0.92
Detection of human metapneumovirus in respiratory secretions by reverse-transcriptase polymerase chain reaction, indirect immunofluorescence, and virus isolation in human bronchial epithelial cells. J Med Virol (2006) 0.92
Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin Exp Immunol (2003) 0.92
Interferon alfa, infectious virus, and virus antigen secretion in respiratory syncytial virus infections of graded severity. Arch Dis Child (1989) 0.91
Targeted case finding for hepatitis B using dry blood spot testing in the British-Chinese and South Asian populations of the North-East of England. J Viral Hepat (2013) 0.91
Alcohol dehydrogenase polymorphisms and predisposition to alcoholic cirrhosis. Hepatology (1993) 0.91
Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice. Gastroenterology (1980) 0.91
The localization of influenza virus in the respiratory tract of ferrets: the different susceptibilities of fresh and maintained organ cultures. J Gen Virol (1977) 0.91
Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut (1998) 0.91
Replication of influenza virus in organ cultures of human endometrium. Lancet (1973) 0.91
Growth characteristics of alpha-foetoprotein-secreting human hepatocellular carcinoma in athymic (nude) mice. Clin Sci (Lond) (1983) 0.91
The pregnant ferret as a model for studying the congenital effects of influenza virus infection in utero: infection of foetal tissues in organ culture and in vivo. Br J Exp Pathol (1977) 0.90
Monoclonal antibodies to feline calicivirus. J Gen Virol (1989) 0.90
Thermal stability and interaction with ferret inflammatory exudates of two clones of influenza virus of differing virulence for both ferrets and man. Br J Exp Pathol (1977) 0.90
Survey of infection in patients receiving antibody replacement treatment for immune deficiency. J Clin Pathol (2002) 0.90
Diagnosis of human metapneumovirus by immunofluorescence staining with monoclonal antibodies in the North-East of England. J Clin Virol (2007) 0.90